BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 2673773)

  • 1. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignancy-associated hypercalcemia].
    Yamaguchi K
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel parathyroid hormone-related protein: role in pathology and physiology.
    Martin TJ; Ebeling PR
    Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P
    Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral hypercalcemia of malignancy: some enigmas on the clinical features.
    Ikeda K; Ogata E
    J Cell Biochem; 1995 Mar; 57(3):384-91. PubMed ID: 7768974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone-related protein.
    Moseley JM; Gillespie MT
    Crit Rev Clin Lab Sci; 1995; 32(3):299-343. PubMed ID: 7495499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
    Stewart AF
    J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of cancer-induced hypercalcemia.
    Rosol TJ; Capen CC
    Lab Invest; 1992 Dec; 67(6):680-702. PubMed ID: 1460860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
    Okazaki R
    Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant humoral hypercalcemia and the parathyroid hormone related protein].
    Jemtland R; Rian E; Gautvik KM
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1738-42. PubMed ID: 2063384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.
    Yamato H; Nagai Y; Inoue D; Ohnishi Y; Ueyama Y; Ohno H; Matsumoto T; Ogata E; Ikeda K
    J Bone Miner Res; 1995 Jan; 10(1):36-44. PubMed ID: 7747629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of the PTHrP gene in squamous carcinomas predicts the occurrence of hypercalcemia in athymic mice.
    Wysolmerski JJ; Vasavada R; Foley J; Weir EC; Burtis WJ; Kukreja SC; Guise TA; Broadus AE; Philbrick WM
    Cancer Res; 1996 Mar; 56(5):1043-9. PubMed ID: 8640759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors.
    Kukreja SC; Shevrin DH; Wimbiscus SA; Ebeling PR; Danks JA; Rodda CP; Wood WI; Martin TJ
    J Clin Invest; 1988 Nov; 82(5):1798-802. PubMed ID: 2846659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of interleukin-6 in uncoupling of bone in vivo in a human squamous carcinoma coproducing parathyroid hormone-related peptide and interleukin-6.
    Nagai Y; Yamato H; Akaogi K; Hirose K; Ueyama Y; Ikeda K; Matsumoto T; Fujita T; Ogata E
    J Bone Miner Res; 1998 Apr; 13(4):664-72. PubMed ID: 9556066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy.
    Stewart AF; Burtis WJ; Wu T; Goumas D; Broadus AE
    J Bone Miner Res; 1987 Dec; 2(6):587-93. PubMed ID: 3455636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.